Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emil Lou

Showing results (11-20 of 184) with videos related to

Pageof 19
Sort By:
Med (New York, N.Y.)|May 19, 2022
Quantity versus quality: Keys to adoptive cell therapy success in breast cancerEmil Lou
Annals of Translational Medicine|June 19, 2018
Translational approaches to investigation of solid tumor malignancies: shifting landscapes, smarter strategies and tactics for therapeutic design, improving patient outcomesEmil Lou
Annals of Translational Medicine|June 19, 2018
The Art of War and oncology: applying the principles of strategy and tactics to greater effect in the era of targeted therapyEmil Lou
Clinical Colorectal Cancer|May 19, 2020
Changing Oncology Treatment Paradigms in the COVID-19 PandemicEmil Lou, Subbaya Subramanian
Biochemical Society Transactions|July 22, 2024
Do tunneling nanotubes drive chemoresistance in solid tumors and other malignancies?Akshat Sarkari, Emil Lou
Physics of Life Reviews|October 13, 2023
Electrical properties of cancer cells: A next generation biophysical therapeutic target: Comment on "The distinguishing electrical properties of cancer cells" by Di Gregorio, Israel, Staelens, Tankel, Shankar, and TuszyńskiAkshat Sarkari, Emil Lou
The American Journal of Medicine|August 5, 2006
A case of tuberculous pericarditis: a rare but deadly diseaseEmil Lou, George L Adams
Southern Medical Journal|January 2, 2007
A case of metoclopramide-induced oculogyric crisis in a 16-year-old girl with cystic fibrosisEmil Lou, Nuhad Abou-Zeid
Cancer Reports (Hoboken, N.J.)|July 31, 2020
Tunneling nanotubes: A bridge for heterogeneity in glioblastoma and a new therapeutic target?Varun Subramaniam Venkatesh, Emil Lou
Neuro-Oncology|March 6, 2021
The past, present, and future management of brain metastases in EGFR-mutant non-small cell lung cancerPaul W Sperduto, Emil Lou
Pageof 19

Showing results (11-20 of 184) with videos related to

Sort By:
Pageof 19
Med (New York, N.Y.)|May 19, 2022
Quantity versus quality: Keys to adoptive cell therapy success in breast cancerEmil Lou
Annals of Translational Medicine|June 19, 2018
Translational approaches to investigation of solid tumor malignancies: shifting landscapes, smarter strategies and tactics for therapeutic design, improving patient outcomesEmil Lou
Annals of Translational Medicine|June 19, 2018
The Art of War and oncology: applying the principles of strategy and tactics to greater effect in the era of targeted therapyEmil Lou
Clinical Colorectal Cancer|May 19, 2020
Changing Oncology Treatment Paradigms in the COVID-19 PandemicEmil Lou, Subbaya Subramanian
Biochemical Society Transactions|July 22, 2024
Do tunneling nanotubes drive chemoresistance in solid tumors and other malignancies?Akshat Sarkari, Emil Lou
Physics of Life Reviews|October 13, 2023
Electrical properties of cancer cells: A next generation biophysical therapeutic target: Comment on "The distinguishing electrical properties of cancer cells" by Di Gregorio, Israel, Staelens, Tankel, Shankar, and TuszyńskiAkshat Sarkari, Emil Lou
The American Journal of Medicine|August 5, 2006
A case of tuberculous pericarditis: a rare but deadly diseaseEmil Lou, George L Adams
Southern Medical Journal|January 2, 2007
A case of metoclopramide-induced oculogyric crisis in a 16-year-old girl with cystic fibrosisEmil Lou, Nuhad Abou-Zeid
Cancer Reports (Hoboken, N.J.)|July 31, 2020
Tunneling nanotubes: A bridge for heterogeneity in glioblastoma and a new therapeutic target?Varun Subramaniam Venkatesh, Emil Lou
Neuro-Oncology|March 6, 2021
The past, present, and future management of brain metastases in EGFR-mutant non-small cell lung cancerPaul W Sperduto, Emil Lou
Pageof 19